Despite decades of research into the biology of AT, there are still no treatment options. Life expectancy is currently just 26.

At Adrestia, we are using our new approach to treating genetic diseases to research and develop a new medicine for this, and other, devastating conditions.

The AT Society supports children and young people with Ataxia-Telangiectasia (AT). They have been tremendously helpful in helping us better understand this complex condition.

As a charity, they offer families an essential lifeline of advising and support through the many challenges they face.

Thank you AT Society, for everything you're doing!